Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Role and expression of FRS2 and FRS3 in prostate cancer

Figure 1

FRS2 and FRS3 mRNA expression in prostate cell lines. A: FRS2 and FRS3 mRNA expression in benign and malignant cell lines as well as protein expression by western blot using FRS2 and FRS3 specific antibodies. B: FRS2 and FRS3 and PSA (positive control) expression in LNCaP cells treated with androgens and assayed at different time points.

Back to article page